Gene expression profiling in human cardiovascular disease

Clinical Chemistry and Laboratory Medicine

Volumn 43, Issue 7, 2005, Pages 696-701

  Steenman, Marja ^a   Lamirault, Guillaume ^a,b   Le Meur, Nolwenn ^a,c   Léger, Jean J ^a,c  

^a L INSTITUT DU THORAX   (France)

^b CHU de Nantes   (France)

^c Parc Scientifique de Luminy   (France)

Author keywords

Cardiovascular disease; Gene expression profiling; Molecular phenotyping

Indexed keywords

CALCIUM ION;

CALCIUM SIGNALING; CANCER; CARDIOVASCULAR DISEASE; CONGENITAL HEART MALFORMATION; DIAGNOSTIC PROCEDURE; DISEASE MARKER; DNA MICROARRAY; ENERGY METABOLISM; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HEART ASSIST DEVICE; HEART FAILURE; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; NORTHERN BLOTTING; PATHOPHYSIOLOGY; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REVIEW;

EID: 26844571342     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2005.118     Document Type: Review

References (30)

1. Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995;270:467-70.
2. Dudda-Subramanya R, Lucchese G, Kanduc D, Sinha AA. Clinical applications of DNA microarray analysis. J Exp Ther Oncol 2003;3:297-304.
3. van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002;415:530-6.
4. Le Meur N, Lamirault G, Bihouée A, Steenman M, Bédrine-Ferran H, Teusan R, et al. A dynamic, web-accessible resource to process raw microarray scan data into consolidated gene expression values: importance of replication. Nucleic Acids Res 2004; 32:5349-58.
5. Yang J, Moravec CS, Sussman MA, DiPaola NR, Fu D, Hawthorn L, et al. Decreased SLIM1 expression and increased gelsolin expression in failing human hearts measured by high-density oligonucleotide arrays. Circulation 2000;102:3046-52.
6. Barrans JD, Stamatiou D, Liew C. Construction of a human cardiovascular cDNA microarray: portrait of the failing heart. Biochem Biophys Res Commun 2001; 280:964-9.
7. Barrans JD, Allen PD, Stamatiou D, Dzau VJ, Liew CC. Global gene expression profiling of end-stage dilated cardiomyopathy using a human cardiovascular-based cDNA microarray. Am J Pathol 2002;160:2035-43.
8. Tan FL, Moravec CS, Li J, Apperson-Hansen C, McCarthy PM, Young JB, Bond M. The gene expression fingerprint of human heart failure. Proc Natl Acad Sci USA 2002; 99:11387-92.
9. Hwang J-J, Allen PD, Tseng GC, Lam C-W, Fananapazir L, Dzau VJ, Liew C-C. Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic endstage heart failure. Physiol Genomics 2002;10:31-44.
10. Steenman M, Chen Y-W, Le Cunff M, Lamirault G, Varro A, Hoffman E, Léger JJ. Transcriptomal analysis of failing and non-failing human hearts. Physiol Genomics 2003;12:97-112.
11. Yung CK, Halperin VL, Tomaselli GF, Winslow RL. Gene expression profiles in end-stage human idiopathic dilated cardiomyopathy: altered expression of apoptotic and cytoskeletal genes. Genomics 2004;83:281-97.
12. Kaab S, Barth AS, Margerie D, Dugas M, Gebauer M, Zwermann L, et al. Global gene expression in human myocardium-oligonucleotide microarray analysis of regional diversity and transcriptional regulation in heart failure. J Mol Med 2004;82:308-16.
13. Grzeskowiak R, Witt H, Drungowski M, Thermann R, Hennig S, Perrot A, et al. Expression profiling of human idiopathic dilated cardiomyopathy. Cardiovasc Res 2003; 59:400-11.
14. Huss JM, Kelly DP. Mitochondrial energy metabolism in heart failure: a question of balance. J Clin Invest 2005; 115:547-55.
15. Paolisso G, Gambardella A, Galzerano D, D'Amore A, Rubino P, Verza M, et al. Total-body and myocardial substrate oxidation in congestive heart failure. Metabolism 1994;43:174-9.
16. Lopaschuk GD. Optimizing cardiac energy metabolism: how can fatty acid and carbohydrate metabolism be manipulated? Coron Artery Dis 2001;12(Suppl 1):S8-11.
17. Eichhorn EJ, Heesch CM, Barnett JH, Alvarez LG, Fass SM, Grayburn PA, et al. Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 1994;24:1310-20.
18. Hasenfuss G. Alterations of calcium-regulatory proteins in heart failure. Cardiovasc Res 1998;37:279-89.
19. 2+ handling in heart failure. J Clin Invest 2005;115:556-64.
20. Rapundalo ST. Cardiac protein phosphorylation: functional and pathophysiological correlates. Cardiovasc Res 1998;38:559-88.
21. Neumann J, Eschenhagen T, Jones LR, Linck B, Schmitz W, Scholz H, et al. Increased expression of cardiac phosphatases in patients with end-stage heart failure. J Mol Cell Cardiol 1997;29:265-72.
22. Carr AN, Schmidt AG, Suzuki Y, del Monte F, Sato Y, Lanner C, et al. Type 1 phosphatase, a negative regulator of cardiac function. Mol Cell Biol 2002;22:4124-35.
23. Margulies KB. Reversal mechanisms of left ventricular remodeling: lessons from left ventricular assist device experiments. J Card Fail 2002;8:S500-5.
24. Blaxall BC, Tschannen-Moran BM, Milano CA, Koch WJ. Differential gene expression and genomic patient stratification following left ventricular assist device support. J Am Coll Cardiol 2003;41:1096-106.
25. Chen Y, Park S, Li Y, Missov E, Hou M, Han X, et al. Alterations of gene expression in failing myocardium following left ventricular assist device support. Physiol Genomics 2003;14:251-60.
26. Hall JL, Grindle S, Han X, Fermin D, Park S, Chen Y, et al. Genomic profiling of the human heart before and after mechanical support with a ventricular assist device reveals alterations in vascular signaling networks. Physiol Genomics 2004;17:283-91.
27. Kaynak B, von Heydebreck A, Mebus S, Seelow D, Hennig S, Vogel J, et al. Genome-wide array analysis of normal and malformed human hearts. Circulation 2003; 107:2467-74.
28. Kittleson MM, Ye SQ, Irizarry RA, Minhas KM, Edness G, Conte JV, et al. Identification of a gene expression profile that differentiates between ischemic and nonischemic cardiomyopathy. Circulation 2004;110:3444-51.
29. Steenman M, Lamirault G, Le Meur N, Le Cunff M, Escande D, Léger JJ. Distinct molecular portraits of human failing hearts identified by dedicated cDNA microarrays. Eur J Heart Fail 2005;7:157-65.
30. Renlund DG, Taylor DO, Kfoury AG, Shaddy RS. New UNOS rules: historical background and implications for transplantation management. United Network for Organ Sharing. J Heart Lung Transplant 1999;18:1065-70.